Cidofovir dihydrateProduct ingredient for Cidofovir

Name: Cidofovir dihydrate
Drug Entry: Cidofovir

Cidofovir is an injectable antiviral medication employed in the treatment of cytomegalovirus (CMV) retinitis in patients diagnosed with AIDS. It suppresses CMV replication through selective inhibition of viral DNA synthesis.^Label It was manufactured by Gilead and initially approved by the FDA in 1996, but has since been discontinued.¹

See full entry for Cidofovir
Accession Number: DBSALT001827
Structure: MOL SDF PDB SMILES InChI
Structure for Cidofovir dihydrate (DBSALT001827)
Synonyms: (((S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)phosphonic acid, dihydrate / ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid dihydrate / 1-((S)-3-hydroxy-2-(phosphonomethoxy)propyl)cytosine dihydrate / Cidofovir hydrate